With at least 4,500 people dead, public-health authorities in west Africa and worldwide are struggling to contain Ebola. Borders have been closed, air passengers screened, schools suspended. But a promising tool for epidemiologists lies unused: mobile cell phone data.
When people make mobile-phone calls, the network generates a call data record (CDR) containing such information as the phone numbers of the caller and receiver, the time of the call and the tower that handled it—which gives a rough indication of the device’s location. This information provides researchers with an insight into mobility patterns...
French scientists are developing a diagnostic tool that works similar to a home pregnancy test and can quickly identify the virus through a tiny fluid sample.
CEA's Ebola testing kit uses strips to rapidly identify the presence of the virus in fluid samples.--Courtesy of France's Atomic Energy Commission
France's Atomic Energy Commission (CEA) is teaming up with European pharma company Vedalab to roll out a user-friendly testing system than could diagnose Ebola in less than 15 minutes, the agency said in a statement. The kit, dubbed "Ebola eZYSCREEN," includes a hand-held device that reads small samples of blood, plasma or urine to detect the virus, and shows results in stripes through a window on the tool.
New York City Council District 7 Community Liason Fidel Malena hands out flyers about Ebola risk near the apartment building of Ebola patient Dr. Craig Spencer, in New York, Friday, Oct. 24, 2014. Spencer remained in stable condition while isolated in a hospital, talking by cellphone to his family and assisting disease detectives who are accounting for his every movement since arriving in New York from Guinea via Europe on Oct. 17. (AP Photo/Richard Drew) | ASSOCIATED PRESS
NEW YORK -- As news of New York City's first confirmed Ebola case spreads through the city, New Yorkers -- even those at the hospital where the patient is being treated, who rode the same subway lines he traveled on and who live in his building -- are remaining markedly calm....
Zachary Hasselbring, a New York University student riding the A train, ...said "I think everybody's overreacting a bit," he said. "It's blown out of proportion."
Workers and volunteers face unease after flying to virus epicenters
Dr. David Schnabel, epidemic intelligence service officer with the Maryland Department of Health and Mental Hygiene, works with database training of Ministry of Health staff at the Bo District Surveillance Office in Sierra Leone in August. (Gbessay Saffa)
"David Schnabel, a former Army doctor who lives in Baltimore, said he hasn’t talked much with people he doesn’t know about his five-week trip to Sierra Leone. Schnabel, who was working for the CDC in the hard-hit Bo District, returned on Sept. 29.
“'I can tell you I did not broadcast where I had been before or after I returned to strangers,” said Schnabel, who trained Sierra Leoneans on Ebola safety protocols rather than caring for patients. “I understood the emotional response to Ebola. To protect myself from any stigma, I consciously was careful who I told.'”
WASHINGTON --In nine days of enhanced screening at five major American airports of passengers from West African countries hit by Ebola, only three of the 552 arrivals had high temperatures, according to Department of Homeland Security statistics. The passengers went through seconary screening and none of them was found to have Ebola, according to a DHS document.
The figures were in a chart contained in DHS statement describing the agency's role in helping counter Ebola with
enhanced screening at airports. The chart covered the period from October 11 when the screening started, through
NEW YORK --The governors of New York and New Jersey announced Friday afternoon that they were ordering all people entering the country through two area airports who had direct contact with Ebola patients in Sierra Leone, Liberia and Guinea to be quarantined.
The announcement comes one day after an American doctor, who had worked in Guinea and returned to New York City earlier in October, tested positive for Ebola and became the first New York patient of the deadly virus.
“A voluntary Ebola quarantine is not enough,” said Gov. Andrew M. Cuomo of New York. “This is too serious a public health situation.”
DOCTORS WITHOUT BORDERS/MEDECINS SANS FRONTIERE OCT. 23, 2014
Doctors without Borders (MSF) describes its specific guidelines and protocols for staff members returning from Ebola assignments. The guidlines were posted following the hospitalization of Dr. Craig Smith, one of its workers, in New York City yesterday.
WASHINGTON - The Obama administration is considering quarantining healthcare workers returning to the United States from the Ebola hot zone of West Africa, after a New York doctor who treated Ebola patients there tested positive for the virus.
Tom Skinner, a spokesman for the U.S. Centers for Disease Control and Prevention, told Reuters on Friday that quarantine is among a number of options being discussed by officials from across the administration.
Staff of the emergency medical services in France (SAMU) wear Ebola virus protection outfits during a press presentation at the Necker Hospital in Paris, October 24, 2014. Credit: Reuters/Philippe Wojazer
"There are a number of options being discussed pertaining to the monitoring and mobility of healthcare workers who are returning to the United States from affected countries," Skinner said.
Extensive background documents from a meeting that took place today at the World Health Organization (WHO) have provided new details about exactly what it will take to test, produce, and bankroll Ebola vaccines, which could be a potential game changer in the epidemic.
ScienceInsider obtained materials that vaccinemakers, governments, and WHO provided to the 100 or so participants at a meeting on “access and financing” of Ebola vaccines. The documents put hard numbers on what until now have been somewhat fuzzy academic discussions. And they make clear to the attendees—who include representatives from governments, industry, philanthropies, and nongovernmental organizations—that although testing and production are moving forward at record speed, knotty issues remain.
GENEVA/LONDON, Oct 24 (Reuters) - Trials of Ebola vaccines could begin in West Africa in December, a month earlier than expected, and hundreds of thousands of doses should be available for use by the middle of next year, the World Health Organization said on Friday.
Vaccines are being developed and made ready in record time by drugmakers working with regulators, the U.N. health agency said, but questions remain about their safety and efficacy which can only be settled by full clinical trials.
"Vaccine is not a magic bullet, but when ready they may be a good part of the effort to turn the tide against the epidemic," senior WHO official Marie-Paule Kieny told a news briefing after a meeting in Geneva of industry executives, global health experts, drug regulators and funders.
Recent Comments